drugset / Trial / NCT07684456
Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is a randomized controlled study.The primary objective is to evaluate the Progression-Free Survival(PFS) of Utidelone Capsule combined with Capecitabine compared with Utidelone Injection combined with Capecitabine in patients with HER-2 negative advanced breast cancer.
Timeline
- Start
- 2026-08-01
- Primary completion
- 2028-03-01
- Completion
- 2029-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epothilone D | Small molecule | 30 mg/m2 | Oral |
| Subject | Epothilone D | Small molecule | 60 mg/m2 | Oral |
| Background | Capecitabine | Small molecule | 1000 mg/m2 | — |